NCT07104331
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07104331
Title SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid Hemangioendothelioma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sarcoma Alliance for Research through Collaboration
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University NOT_YET_RECRUITING Stanford California 94305 United States Details
University of Colorado NOT_YET_RECRUITING Aurora Colorado 80203 United States Details
Brigham and Women's Hospital NOT_YET_RECRUITING Boston Massachusetts 02115 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Washington University St. Louis NOT_YET_RECRUITING St Louis Missouri 63130 United States Details
Sloan Kettering Institute for Cancer Research NOT_YET_RECRUITING New York New York 10065 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field